Men taking valproate and their partners are being advised to use effective contraception because of new data suggesting a potential small increased risk of harm to children if valproate is used by a father at conception.
The Medicines and Healthcare products Regulatory Agency (MHRA) have published a Drug Safety Update, which includes information and advice for healthcare professionals and patients.
Pharmacy teams should continue to dispense valproate. They should be prepared to discuss the new advice with patients.
We have sent an email update to all pharmacy professionals to highlight the new advice.